Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Japan.
Department of Pathology, Saitama Cardiovascular and Respiratory Center, Japan.
Intern Med. 2023 Dec 15;62(24):3609-3617. doi: 10.2169/internalmedicine.2433-23. Epub 2023 Sep 29.
Objective To clarify both the histologic changes in primary viral pneumonia other than COVID-19 and whether patients with severe lung injury (SLI) on biopsy specimens progress to severe respiratory insufficiency. Methods Patients with primary viral pneumonia other than COVID-19, who underwent lung tissue biopsy, were retrospectively studied. Patients Forty-three patients (41 living patients and 2 autopsied cases) were included in the study. Results Nine patients had SLI, whereas most of patients who recovered from primary viral pneumonia showed a nonspecific epithelial injury pattern. One patient underwent a biopsy under mechanical ventilation. Two of 8 (25.0%) patients on ambient air or low-flow oxygen therapy progressed to a severe respiratory condition and then to death, while only 1 (3.1%) of 32 patients without SLI progressed to a severe respiratory condition and death (p=0.096). The proportion of patients who required O treatment for ≥2 weeks was higher in patients with SLI than in those without SLI (p=0.033). The 2 autopsy cases showed a typical pattern of diffuse alveolar damage, with both showing hyaline membranes. Non-specific histologic findings were present in 32 patients without SLI. Conclusion Some patients with SLI progressed to severe respiratory insufficiency, whereas those without SLI rarely progressed to severe respiratory insufficiency or death. The frequency of patients progressing to a severe respiratory condition or death did not differ significantly between those with and without SLI. The proportion of patients who required longer O treatment was higher in SLI group than in those without SLI.
目的 阐明除 COVID-19 以外的原发性病毒性肺炎的组织学变化,以及活检标本中有严重肺损伤 (SLI) 的患者是否会进展为严重呼吸功能不全。
方法 对接受肺组织活检的除 COVID-19 以外的原发性病毒性肺炎患者进行回顾性研究。
结果 共纳入 43 例患者(41 例存活患者和 2 例尸检病例)。9 例患者有 SLI,而大多数从原发性病毒性肺炎中恢复的患者表现出非特异性上皮损伤模式。1 例患者在机械通气下行活检。8 例接受环境空气或低流量氧疗的患者中,有 2 例(25.0%)进展为严重呼吸状况,继而死亡,而 32 例无 SLI 的患者中仅 1 例(3.1%)进展为严重呼吸状况和死亡(p=0.096)。有 SLI 的患者需要接受 O 治疗≥2 周的比例高于无 SLI 的患者(p=0.033)。2 例尸检病例均表现为弥漫性肺泡损伤的典型模式,均有透明膜形成。32 例无 SLI 的患者表现出非特异性组织学发现。
结论 一些 SLI 患者进展为严重呼吸功能不全,而无 SLI 的患者很少进展为严重呼吸功能不全或死亡。有 SLI 和无 SLI 的患者进展为严重呼吸状况或死亡的频率无显著差异。需要接受 O 治疗较长时间的患者比例在 SLI 组高于无 SLI 组。